Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- BUSINESS NEWS IN BRIEF -2-
October 22, 2001
- Sugi Yakkyoku: Sales, Profits Up Over 30% in First Half
October 22, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF
October 22, 2001
- OTC NEW IN BRIEF
October 22, 2001
- NOTICE
October 22, 2001
- Usefulness of Aspirin Underlined: Dr Hennekens
October 22, 2001
- NHI Price Ceiling to Be Set: Reform Proposal -1-
October 22, 2001
- DIAGNOSTIC NEWS IN BRIEF
October 22, 2001
- NHI Price Ceiling to Be Set: Reform Proposal -2-
October 22, 2001
- 60th Annual Meeting of the Japanese Cancer Association
October 22, 2001
- MOF Proposes 30% Copayment Rate for All Patients
October 22, 2001
- COPD Prevalence Reaches 8.5% in Japanese over 40: Dr Fukuchi
October 22, 2001
- Inhalant Steroids Are Effective for Asthma: Yomiuri, GSK Forum
October 15, 2001
- Bayer to File NDA for Vardenafil by Year-end in Japan
October 15, 2001
- Sysmex Aims at \72 Bil. Sales, 7.5% ROE in FY2004
October 15, 2001
- Ohmori, Sanuki, Baikado Tie Up to Cover Entire Shikoku Market
October 15, 2001
- Toshiba Develops 0.25mm Multi-slice CT Technology
October 15, 2001
- Sales Up for 23 Generic Houses, Down for 22: EMA Survey
October 15, 2001
- Guidant Japan to Introduce New Defibrillator
October 15, 2001
- BUSINESS NEWS IN BRIEF -1-
October 15, 2001
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…